Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1278
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06034431 | Increasing Access to Definitive Treatment for Prostate Cancer | ||
| NCT00512889 | Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | ||
| NCT03910296 | Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain | ||
| NCT00021996 | Valdecoxib in Treating Chronic Pain in Cancer Patients | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT00142428 | Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma | ||
| NCT03070145 | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy | ||
| NCT00442130 | Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination | ||
| NCT00003045 | Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer | ||
| NCT05565638 | PROFAST Intervention in Precursor Multiple Myeloma | ||
| NCT05837884 | Predicting Progression of Developing Myeloma in a High-Risk Screened Population | ||
| NCT06831552 | Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma | ||
| NCT07095998 | Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy | ||
| NCT01853748 | T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | ||
| NCT00548717 | Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation | ||
| NCT03749421 | Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer | ||
| NCT01441765 | PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine | ||
| NCT00369226 | Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation | ||
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | ||
| NCT06564233 | Supportive Care Intervention for Outpatient Stem Cell Transplant Patients | ||
| NCT02787369 | ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL | ||
| NCT01970358 | A Phase I Study with a Personalized NeoAntigen Cancer Vaccine in Melanoma | ||
| NCT02774850 | Home Away From Home - Medical Outcomes | ||
| NCT03602885 | EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | ||
| NCT00894855 | Skin Cancer Screening and Education at Beaches | ||
| NCT03762590 | GENetic Education Risk Assessment and TEsting Study | ||
| NCT00911820 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | ||
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer | ||
| NCT00142467 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma | ||
| NCT04883671 | Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial | ||
| NCT00146601 | Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | ||
| NCT04356729 | A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma | ||
| NCT00366457 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | ||
| NCT03483012 | Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis | ||
| NCT02592330 | Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft | ||
| NCT00060099 | SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia | ||
| NCT01961128 | RPFNA Assessment of Exercise Effect in Breast Cancer | ||
| NCT05535192 | TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients | ||
| NCT05335434 | Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT00869999 | Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT04724499 | Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy | ||
| NCT03717402 | Smartphone Technology to Alleviate Malignant Pain (STAMP) | ||
| NCT03075072 | Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial | ||
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | ||
| NCT03436654 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | ||
| NCT00948688 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | ||
| NCT04879927 | Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement |
